[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:fontan-circulation":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":22,"states":23},"Fontan Circulation",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06324396","IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease",[11],"Phase 1","RECRUITING","2026-08-26T02:16:54.044282Z","2026-05-05T02:43:26.979729Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06762964","CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation",[19],"Phase 2","2026-08-26T02:17:05.172421Z","2026-05-05T02:43:28.475327Z",[],[]]